Good as gold
Researchers at the Massachusetts Institute of Technology believe that tiny gold particles could target and destroy tumours in a patient’s body with minimal side effects.

Researchers at the Massachusetts Institute of Technology (
) believe that tiny gold particles could target and destroy tumours in a patient’s body with minimal side effects.
Such particles, known as gold nanorods, would absorb energy from near-infrared light and emit it as heat to destroy the tumours.
The nanorods could diagnose as well as treat tumours, according to MIT graduate student Geoffrey von Maltzahn, who developed the tumour-targeting particles with Sangeeta Bhatia, professor in the Harvard-MIT Health Sciences and Technology (HST) division.
Cancer is expected to affect up to 15 million people by 2020. Currently, most patients are treated with chemotherapy or radiotherapy, which are often effective but can have debilitating side effects because it is difficult to preciscely target tumour tissue.
With chemotherapy treatment, 99 per cent of drugs administered do not typically reach the tumour, said von Maltzahn. In contrast, the gold nanorods can specifically focus heat on tumours.
‘This class of particles provides the most efficient method of specifically depositing energy in tumours,’ he said.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
I´m sure politicians will be thumping tables and demanding answers - while Professor Bell, as reported above, says ´wait for detailed professional...